Abstract:Background: Fat mass and obesity-associated protein (FTO) is a critical N6-methyladenosine (m6A) demethylase that participates in tumorigenesis and is associated with the prognosis of patients in some cancers. However, the key roles of FTO in pan-cancer are still largely obscure. Methods: FTO expression levels in pan-cancer were estimated via the Genotype-Tissue Expression (GTEx), Cancer Cell Line Encyclopedia (CCLE), and The Cancer Genome Atlas (TCGA) databases. Univariate survival analysis was used to estimate the effects of FTO on prognosis. In addition, we used the Tumor Immune Evaluation Resource (TIMER) to assess the immune cell infiltration of FTO gene across cancers. The association of FTO expression with immune checkpoint genes expression, DNA mismatch repair (MMR) gene mutation, DNA methyltransferases, microsatellite instability (MSI), and tumor mutational burden (TMB) was investigated using Spearman's correlation analysis. Moreover, Gene Set Enrichment Analysis (GSEA) was utilized to identify critical pathways in cancers. The STRING website was used to reveal the protein-protein interaction (PPI) network of FTO. Results: FTO was aberrantly expressed across cancers and survival analysis demonstrated that its expression was associated with clinical prognosis of many cancer patients. Specifically, FTO expression was significantly associated with immune infiltrating cells in colon adenocarcinoma, kidney renal clear cell carcinoma, and liver hepatocellular carcinoma. In addition, FTO expression was significantly associated with immune checkpoint genes expression, MMR, DNA methyltransferases levels, TMB, and MSI in multiple cancers. Moreover, the GSEA unveiled that FTO was involved in the regulation of tumors and immune-related signaling pathways. In addition, several m6A related genes were implicated in the PPI network of FTO. Conclusion: FTO was related to patients' prognosis and tumor immune infiltrates in various cancers, and may serve as a novel and potential prognostic and immune biomarker in human pan-cancer.

Roles of FTO Gene in Tumor Metabolism

FTO gene polymorphisms and obesity risk in Chinese population: a meta-analysis

The Role of FTO in Tumors and It's Research Progress.

Studies on the fat mass and obesity-associated (FTO) gene and its impact on obesity-associated diseases

The Role of FTO in Tumors and Its Research Progress

FTO – A Common Genetic Basis for Obesity and Cancer

Overexpression of the Fat Mass and Obesity Associated Gene (fto) in Breast Cancer and Its Clinical Implications

The Potential Role of N6-Methyladenosine (m6A) Demethylase Fat Mass and Obesity-Associated Gene (FTO) in Human Cancers

FTO Gene: a New Target for Obesity Treatment

The lipid metabolism gene FTO influences breast cancer cell energy metabolism via the PI3K/AKT signaling pathway

Study on the function of fat mass and obesity-associated protein in pancreatic cancer cell

Fat mass and obesity-associated gene expression and its biological function in colon cancer tissues

The Role of FTO Risk Haplotype in Overweight/Obesity and Lipid Parameters‐Results From the Central China Population Study

Polymorphism in 5 ' Regulatory Region of the Porcine Fat Mass and Obesity Associated (fto) Gene is Associated with Intramuscular Fat Content in A Jinhua X Pietrain F-2 Reference Population

Regulation of Fat Mass and Obesity Associated Gene in Animal Fat Metabolism：A Review

The Role of the Fat Mass and Obesity-Associated Protein in the Proliferation of Pancreatic Cancer Cells

Estrogen Induces Endometrial Cancer Cell Proliferation and Invasion by Regulating the Fat Mass and Obesity-Associated Gene Via PI3K/AKT and MAPK Signaling Pathways

Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker

Fat Mass and Obesity Associated (FTO) Gene and Hepatic Glucose and Lipid Metabolism

FTO gene polymorphisms and obesity risk: a meta-analysis

FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis